3 million wrongly treated after false positives from mammograms The Susan G.

What scientists should be developing is real scanning technology that goes after the mammogram itself, exposing its low energy radiation effects on individual cells! When DNA is usually subjected to low energy radiation defer by mammograms, the genes which are vunerable to breast cancer, BRCA2 and BRCA1, actually interfere with your body’s personal repairing DNA mechanism. Because the physical body tries to reduce the carcinogens that are welcomed in by the radiation, it becomes more vunerable to developing cancer.Of the amount, approximately $900,000 was paid in money and $200,000 was paid in ARYx common stock. ARYx had no revenue during the first quarter of 2010 or 2009. Research and development expenses for the first one fourth of 2010 were $2.2 million compared to $6.8 million in the first quarter of this past year. Included in research and development expenses in the initial quarter of 2010 had been costs related to the close-out of the 600 individual EmbraceAC trial of tecarfarin that was finished in the second fifty % of 2009. Costs in the first one fourth of 2009 were higher than in 2010 2010 because of both EmbraceAC trial and the close-out of the Stage 2b trial of budiodarone, the business’s product applicant for the treatment of atrial fibrillation.